rs782276356
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_001032382.2(PQBP1):c.489C>T(p.Arg163=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,206,752 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 35 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R163R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001032382.2 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PQBP1 | NM_001032382.2 | c.489C>T | p.Arg163= | synonymous_variant | 5/7 | ENST00000447146.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PQBP1 | ENST00000447146.7 | c.489C>T | p.Arg163= | synonymous_variant | 5/7 | 1 | NM_001032382.2 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000540 AC: 6AN: 111177Hom.: 0 Cov.: 22 AF XY: 0.0000300 AC XY: 1AN XY: 33361
GnomAD3 exomes AF: 0.0000403 AC: 7AN: 173719Hom.: 0 AF XY: 0.0000668 AC XY: 4AN XY: 59909
GnomAD4 exome AF: 0.000120 AC: 132AN: 1095575Hom.: 0 Cov.: 35 AF XY: 0.0000941 AC XY: 34AN XY: 361273
GnomAD4 genome ? AF: 0.0000540 AC: 6AN: 111177Hom.: 0 Cov.: 22 AF XY: 0.0000300 AC XY: 1AN XY: 33361
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 10, 2015 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 23, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Aug 04, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at